l General Information |
Product Name | S107 |
General description | S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels. |
Synonym | 7-methoxy-4-methyl-3,5-dihydro-2H-1,4-benzothiazepine; S 107; S-107 |
Purity | ≥98.5%(HPLC) | CAS Number | 927871-76-9 |
Formula | C11H15NOS | Molecular Weight | 209.307 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Off-white or pale yellow solid |
l Biological Information |
Biochem/Physiol Actions | S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
